Related Experiment Video

Updated: Dec 11, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

3.3K

16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid

Ricard Cervera1, Ignasi Rodríguez-Pintó2, Kim Legault3

  • 1Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Catalonia, Spain.

Lupus
|August 22, 2020
PubMed

Insights

The Catastrophic Antiphospholipid Syndrome (CAPS) Task Force convened in 2019 to review current knowledge on CAPS pathogenesis, diagnosis, and treatment. This summary covers key findings presented at the meeting.

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • The 16th International Congress on Antiphospholipid Antibodies (aPL) hosted a meeting of the Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) in September 2019.
  • Antiphospholipid Syndrome (APS) is an autoimmune disorder characterized by recurrent thrombosis and/or pregnancy morbidity, with CAPS representing its most severe manifestation.

Purpose of the Study:

  • To consolidate and present the latest scientific understanding of Catastrophic Antiphospholipid Syndrome (CAPS).
  • To cover critical aspects including pathogenesis, clinical and laboratory features, diagnostic criteria, precipitating factors, and therapeutic strategies for CAPS.

Main Methods:

  • The content is based on discussions and presentations from the CAPS Task Force meeting held during the 16th International Congress on Antiphospholipid Antibodies.
  • This article serves as a summary of the expert consensus and updated information shared at the congress.

Main Results:

  • The meeting focused on synthesizing current knowledge across the spectrum of CAPS.
  • Key areas of discussion included advancements in understanding the mechanisms, clinical presentation, diagnostic approaches, triggers, and management of CAPS.

Conclusions:

  • The article provides a comprehensive overview of the state-of-the-art knowledge on CAPS as presented in September 2019.
  • It aims to guide clinicians and researchers by summarizing essential information on this critical condition.

Keywords:
Anticardiolipin antibodiesantiphospholipid syndromecatastrophic antiphospholipid syndrome

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.2K
A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

5.4K

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
266
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
152
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
122
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
179
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
919
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
135